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Summary Epidemiologic data indicate that electroconvulsive therapy (ECT) does
not precipitate epilepsy. However, when an ECT patient develops this condition, one is
faced with the question as to whether ECT caused it and whether ECT can be safely
continued. We describe four patients, two of whom developed definite epilepsy and
two possible epilepsy during extended courses of ECT. In one of the patients ECTwas
stopped at that point, but in the other three, ECTwas continued without complica-
tions or apparent precipitation of spontaneous seizures. We describe some of the
clinical challenges in this scenario and provide recommendations regarding continued
use of ECT in the newly diagnosed epileptic patient.
# 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Electroconvulsive therapy (ECT) involves the induc-
tion of a generalized seizure with an electrical
current. It was developed in 1938 and is widely used
throughout the world in the treatment of severe
depressive illness, mania, and schizophrenia.1 It is
estimated that approximately 100,000 patients in
the USA per year are treated with ECT.1 Treatments
are typically administered twice or thrice weekly
until clinical improvement occurs. An average
course of therapy for an acute episode of illness is
6—10 treatments. Patients with highly medication-
refractory or recurrent illnesses often receive* Corresponding author. Tel.: +1 507 284 3789;
fax: +1 507 284 4158.
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doi:10.1016/j.seizure.2006.12.002maintenance treatments at spaced intervals, typi-
cally once every 1—4 weeks, for extended periods of
time to prevent relapse.
ECTwas developed, at least in part, on the theory
that there is a biological antagonism between sei-
zures and severe psychopathologic states such as
psychosis.2 While the intentional induction of sei-
zures may on first blush appear to be a risk for
inducing spontaneous seizures, several large-scale
epidemiologic surveys find no evidence that ECT
causes epilepsy.3—5 In fact, much evidence indicates
that ECT actually has anticonvulsant properties.6
For example, in animal models, ECT (or electrocon-
vulsive shock, as it is referred to in animals) has
potent anti-kindling effects.7 In humans, as a course
of treatments progresses, the amount of electrical
charge needed to induce seizures increases, and
the length of seizures shortens, indicating antic-
onvulsant effects.6 Finally, there is an intriguing. Published by Elsevier Ltd. All rights reserved.
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may reduce the frequency of spontaneous seizures,
and in the pre-antiepileptic drug era, ECTwas used
in some circumstances for this very purpose.8—22
Nonetheless, the occurrence of spontaneous epi-
lepsy is not uncommon in the general population.
Whereas it would be statistically highly unlikely for
epilepsy to occur in a patient who only is receiving a
2—4 week course of ECT, maintenance courses of
ECT can extend several years for chronically ill
patients. Thus, a clinician treating a large number
of maintenance ECT patients may expect an occa-
sional one to develop epilepsy. Some of the chal-
lenges in such cases include determining whether
ECT may have played a role in initiating the spon-
taneous seizures, how to control the epilepsy, and
whether continued ECT can be administered safely
and effectively. To our knowledge, there are no
reports of such patients in the modern literature.
There are numerous case reports of psychiatrically
ill epileptic patients who receive ECTwithout appar-
ent increase in spontaneous seizures.10,23—26
At our facility, we treat approximately 300
patients per year with ECT. In reviewing our data-
base over approximately the past decade, we found
four patients receiving maintenance ECTwho devel-
oped definite or possible epilepsy. In three cases,
continued ECT treatments were undertaken without
complication. In one case, ECTwas discontinued. We
describe these patients in detail and provide recom-
mendations for clinical practice. Of note, all EEGs in
this series were interpreted by Mayo Clinic neurol-
ogists with specialized training in epileptology.Case reports
Case 1
A 55-year-old divorced white female with a long
history of recurrent bouts of depression and multi-
ple medication and psychotherapy trials presented
for her index hospitalization at our facility. She had
received an uncomplicated, highly effective course
of ECT treatments in her mid-40s without mainte-
nance ECT. Medical history was negative for spon-
taneous seizures or risk factors thereof and positive
for carpal tunnel syndrome, hysterectomy, and sev-
eral non-specific chronic pain syndromes (headache,
backache, and arthralgias). For the index hospita-
lization (at age 55), she received six ECT treatments
with resolution of her depressive syndrome. She
relapsed approximately 2 months later while taking
citalopram and received another six treatments.
She was discharged on mirtazapine and lithium.
She again rapidly relapsed within a few weeks andECTwas commenced again, this time with the insti-
tution of maintenance ECT. Over approximately the
next 32 months, she received 124 treatments. There
was a break about midway through this course of
about 4 months when she did not receive any treat-
ments. Her depressive illness typically responded
very well to index courses of thrice weekly treat-
ments with fairly good maintenance of remission
status during maintenance ECT; however, we were
not able to stretch the inter-treatment interval to
beyond once every 10—14 days. During this time,
several high-dose, extended-duration psychotropic
medication trials were attempted including mirta-
zapine (lithium was stopped upon resumption of
ECT), bupropion, nefazodone, desipramine, escita-
lopram, tranylcypromine, and methylphenidate.
Approximately 1 month before the last ECT treat-
ment, her sons noticed brief (about 2 min) spells of
unresponsiveness, jerking movements, and occa-
sional incontinence of urine. There were five wit-
nessed episodes over a month’s time. EEG revealed
activation of bitemporal spikes with sleep. Head MRI
was normal. There was no family history of epilepsy.
Her neurologist, a specialist in epilepsy, diagnosed
complex partial seizures and started her on carba-
mazepine. ECT was discontinued and duloxetine
instituted for depression. Over follow up the next
year and a half, there have been no other seizures.
Depression severity has been waxing and waning but
generally stable and there have been no psychiatric
hospitalizations. Of note, from the time of first
known complex partial seizure, there were approxi-
mately seven more ECT treatments before the diag-
nosis of epilepsy was made and ECTstopped. None of
these latter treatments involved any complications.
Case 2
This patient was a 39-year-old single white male
with a several-decade history of bouts of depression
superimposed over chronic dysthymia. He had a
remote history of alcohol abuse in remission for
over a decade. Personal and family history was
negative for seizures. Medical history was positive
for mild bilateral hearing loss. He had been treated
with several psychotropic medications over the
years. He was referred for ECT in a major depressive
episode. He responded well to index treatments and
maintenance treatments were commenced. Over an
approximately 7-month period, he received 39 ECT
treatments. At that time, he revealed an approxi-
mately 2-month history of staring spells. His only
psychotropic medication was mirtazapine. EEG
revealed bilateral epileptiform activity while head
MRI showed bilaterally symmetric increased T2 sig-
nal in the hippocampi with slight left posterior
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nosed complex partial epilepsy and started him on
carbamazepine. ECT was discontinued. There was
good control of the seizures, but approximately 4
months later, severe depression returned and ECT
was resumed. Over the next approximately year and
a half, 40 treatments were administered and then
stopped due to stable clinical status. His seizure
disorder remained under good control. During the
time on carbamazepine, there was never any trou-
ble inducing seizures at ECT sessions. Psychotropic
medications that were prescribed along with ECT
during the period after epilepsy was diagnosed
included, at various times, atomoxetine, trazodone,
nefazodone, olanzapine, and modafanil.
Case 3
This patient was an 89-year-old widowed white
female with an approximately 1-year history of
dementia, with amore remote history of unspecified
mood disorder. In the months after a myocardial
infarction, her behavior degenerated into a severe
state of delusionality and agitation. Past medical
history, in addition to coronary artery disease,
included hypertension, hypothyroidism, macular
degeneration, esophagitis, and hiatal hernia. She
had no personal or family history of epilepsy. At
index psychiatric hospitalization at age 89, she
received three ECT treatments with excellent psy-
chopathologic resolution. She was discharged on
citalopram but was readmitted a week later with
fulminant relapse. Threemore ECT treatments were
again successful; citalopram was discontinued and
maintenance ECT was commenced. Over approxi-
mately the next 2.5 years, she received a total of 69
ECT treatments at intervals usually of every other
week to sustain clinical improvement. Her only
psychotropic medication during the entire time
was quetiapine.
Approximately halfway through this extended
course of maintenance ECT, she was noted to have
spells of shaking that lasted a fewminutes. There did
not seem to be loss of consciousness or incontinence.
A neurologist specializing in epilepsy felt these to be
of indeterminate etiology and ordered an EEG, which
showed bitemporal but right dominant spikes and
sharp waves that were felt to be potentially epilep-
togenic. Head computed tomography showed an old
right parietal lobe infarct. She was started on depa-
kote, which she received for the remaining 35 ECT
treatments administered over the next approxi-
mately year and a half. Of note, the spells seemed
to stop before the depakote was started. There was
no trouble inducing seizures at ECTsessions in spite of
depakote. ECT was eventually discontinued due toweakening physical status due to congestive heart
failure, and she expired approximately 2 months
after the last treatment.
Case 4
At index hospitalization at our facility, this was a 28-
year-old married white female with a very extensive
history of mood disorder and numerous psychiatric
hospitalizations. She had been diagnosed with bipo-
lar II disorder. She was given six ECT treatments for a
depressive episode with apparent good results. She
had no personal or family history of epilepsy and had
no significant medical problems. Over the next
approximately 2 years and 10 months, she received
86 ECT treatments for her highly recurrent, medica-
tion-refractory mood disorder. Most of her acute
psychiatric presentations were for depression but
occasionally for mixed depressive-hypomanic
states. She was treated pharmacologically with
quetiapine, carbamazepine (for manic prophylaxis),
and bupropion for most of her ECT course.
During a hospitalization in which she received
the last two of the 86 treatments, the diagnosis of
possible epilepsy was made. This was based upon
an episode of a spell, lasting approximately 30 s,
which had occurred approximately 5—6 months
earlier at home during which her husband noted
her to be unresponsive to verbal cues and to appear
to be choking. There were no tonic or clonic move-
ments. At that time, the aspects of the spell were
reported to her psychiatrist, who felt the differ-
ential diagnosis included a seizure, panic attack, or
dissociative episode. She was already on carbama-
zapine, the dose of which was increased with a
plan for watchful waiting. She had no further
spells. However, during the hospitalization 5—6
months later, the decision was made to discontinue
the carbamazapine due to loss of psychotropic
efficacy. After 5 days off carbamazapine, an EEG
was obtained which showed generalized atypical
spike and wave bursts. Head MRI with and without
gadolinium enhancement was normal. A neurology
consultant recommended instituting lamotrigine.
She had already had two ECT treatments in this
hospitalization, and further ECT was held at that
point. A few weeks later, after hospital discharge,
she was noted to have another spell. Lamotrigine
dose was increased. Four months later she was
again hospitalized for depression, and two ECT
treatments were administered without apparent
complications. Three years after that, review of
her medical chart reveals periodic hospitalizations
for her mood disorder, numerous psychotropic
trials, and no ongoing clinical evidence of sponta-
neous seizures.
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ECT is an indispensable treatment for some patients
with highly recurrent, chronic, and psychotropic
medication-refractory psychiatric illnesses.
Extended courses of maintenance ECT may be
necessary to sustain the benefits gained by an initial
series of thrice-weekly treatments and may go on
for many months or even years. As such, the risk of
spontaneous epilepsy increases not necessarily as a
result of the treatments per se but rather because
new-onset epilepsy is not a terribly uncommon con-
dition. It is our opinion that in this rare scenario,
attempts should be made to discontinue ECT but
that if needed, further treatments can probably be
carried out practicably and safely.
When a patient receiving maintenance ECT
develops epilepsy or, in the absence of definite
clinical seizures, epileptogenic EEG activity, several
issues need to be addressed by the psychiatric
clinician. Presumably, some type of clinical events,
or ‘‘spells,’’ have occurred which have lead to a
neurological evaluation. The psychiatrist should
communicate with the attending neurologist to
coordinate the plan of care. A typical maintenance
ECT patient is receiving the treatments at spaced
intervals of 1—4 weeks, which should allow a thor-
ough neurologic evaluation (e.g., office consulta-
tion, head imaging, and EEG) to be performed
before the next scheduled treatment. One must
consider whether ECT may have played an etiologic
role in causing the epilepsy. In all likelihood, no
definitive answer will be obtained. However, a con-
servative approach would be to stop further ECT.
However, presumably the patient was receiving
ongoing ECT because of a history of a highly recur-
rent, medication-refractory illness, so such a strat-
egy may result in return of the psychopathology.
Furthermore, if cessation of ECT is considered, then
presumably a more aggressive psychopharmacologic
approach would be considered which may have pro-
convulsant effects.
If review of the patient’s psychiatric condition
leads to the conclusion to continue ECT, the next
question is, will ECT aggravate the new-onset
seizure disorder? In all four of our patients, at
least one ECT treatment was given after onset of
the epilepsy (or abnormal EEG), and in two cases,
extended ECT was given. None of the patients
seemed to show any apparent spontaneous seizure
activity during ECT after this time point. In fact, a
likely more problematic issue for the ECT clinician
is how to administer ECT effectively to a patient
taking anti-epileptic medication, which presum-
ably would make it more difficult to initiate sei-
zures at ECT sessions. In the three of our patientswho were taking anticonvulsant medication (car-
bamazepine in two cases and lamotrigine in one),
further ECT seizures were easily obtained. How-
ever, ongoing communication between the treat-
ing psychiatrist and the neurologist is necessary
should ECT seizures become impossible to achieve
so that the lowest effective AED dose can be used
and even a switch to another agent can be tried if
needed.
There are some limitations to our case series.
First, we cannot say whether ECT played an etiologic
role in the development of epileptogenic activity.
Indeed, many maintenance ECT patients have coex-
isting factors, such as neurological disorders, sub-
stance dependence, or concomitant psychotropic
medications that may influence the development
of epilepsy. At most, we can conclude that if epi-
lepsy occurs during the course of maintenance ECT,
the treatments can be continued safely. Second, the
readings of the EEGs of course are subjective and
open to interpretation by different clinical neuro-
physiologists. It is possible that some of the EEGs
from our patient series would have been interpreted
differently by other clinicians. Third, in the absence
of video—EEG monitoring, we cannot rule out the
possibility of pseudoseizures in some of our patients
or even the possibility that some of the epileptiform
activity on EEG may have pre-dated the ECT treat-
ments. Still, we feel this series outlines the chal-
lenges the ECT clinician faces and does provide
sound recommendations for clinical practice.References
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